rs121909547
|
|
A |
0.800 |
GeneticVariation |
CLINVAR |
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders.
|
31064749 |
2019 |
rs121909551
|
|
A |
0.800 |
GeneticVariation |
CLINVAR |
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders.
|
31064749 |
2019 |
rs121909567
|
|
A |
0.800 |
GeneticVariation |
CLINVAR |
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders.
|
31064749 |
2019 |
rs121909551
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
SERPINC1 gene mutations in antithrombin deficiency.
|
28317092 |
2017 |
rs121909552
|
|
T |
0.800 |
GeneticVariation |
CLINVAR |
Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency.
|
28300866 |
2017 |
rs121909551
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.
|
26748602 |
2016 |
rs121909551
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site.
|
27322195 |
2016 |
rs121909552
|
|
T |
0.800 |
GeneticVariation |
CLINVAR |
Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.
|
26748602 |
2016 |
rs121909551
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Discordant diagnoses obtained by different approaches in antithrombin mutation analysis.
|
24956267 |
2014 |
rs121909552
|
|
T |
0.800 |
GeneticVariation |
CLINVAR |
Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population.
|
24162787 |
2014 |
rs121909546
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909547
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909548
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909549
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909550
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909551
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909551
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Use of recombinant human antithrombin concentrate in pregnancy.
|
24082793 |
2013 |
rs121909551
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909552
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909554
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909555
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909557
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909558
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909563
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |
rs121909564
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture.
|
23910795 |
2013 |